Dkk2-flox Mouse
一般名
Dkk2-flox
製品ID
S-CKO-12248
背景情報
C57BL/6JCya
系統ID
CKOCMP-56811-Dkk2-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Dkk2-flox Mouse(カタログ番号S-CKO-12248)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Dkk2-flox
系統ID
CKOCMP-56811-Dkk2-B6J-VA
遺伝子名
製品ID
S-CKO-12248
遺伝子別名
--
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 3
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000029665
NCBIトランスクリプトID
NM_020265
ターゲット領域
Exon 2
有効領域の大きさ
~1.4 kb
遺伝子研究の概要
DKK2, also known as Dickkopf associated protein 2, is a secretory protein. It is known as an inhibitor of canonical Wnt/β-catenin signaling, and this signaling is crucial for the maintenance of muscle and bone [3]. DKK2 is involved in multiple biological processes and diseases. It plays a role in the interaction between muscle and bone, and in tumor-related processes such as angiogenesis, tumor cell proliferation, migration, invasion, and immune evasion [3][2][1][4][5].
In androgen-deficient mice, orchidectomy significantly enhanced Dkk2 mRNA levels in the soleus muscles and serum Dkk2 levels. Serum Dkk2 levels were negatively related to trabecular bone mineral density, suggesting Dkk2 might be involved in androgen deficiency-induced muscle wasting and osteopenia [3].
In oral squamous cell carcinoma (OSCC), compared to normal tissues, DKK2 expression was elevated. Hypoxic conditions could promote DKK2 expression. DKK2 overexpression promoted cell proliferation, migration, and invasion of OSCC cells, while DKK2 knockdown inhibited these processes by regulating the PI3K/AKT signaling pathway [1].
In colorectal cancer, DKK2 could stimulate angiogenesis via accelerating the aerobic glycolysis of CRC cells and promoting lactate secretion. It might be a potential anti-angiogenic target [2]. Also, DKK2 blockage enhanced anti-angiogenic therapy of Kras mutated colorectal cancer by activating tumor infiltrating CD8+ T cells and reducing angiogenesis [4].
In pancreatic ductal adenocarcinoma, elevated DKK2 expression predicted poorer prognosis, and knockdown of DKK2 in PDAC cells resulted in impaired cellular migration [5].
In conclusion, DKK2 has diverse functions in biological processes such as muscle-bone interaction. In disease areas, especially in multiple cancers including OSCC, colorectal cancer, and pancreatic ductal adenocarcinoma, DKK2 plays significant roles in tumor progression, angiogenesis, and immune evasion. The study of DKK2 in mouse models helps to understand its role in these biological processes and diseases, providing potential targets for treatment.
References:
1. Guo, Wenbo, Qu, Yun, Yu, Yang, Hu, Tenglong, Zhou, Shan. 2024. DKK2 promotes the progression of oral squamous cell carcinoma through the PI3K/AKT signaling pathway. In Aging, 16, 9204-9215. doi:10.18632/aging.205864. https://pubmed.ncbi.nlm.nih.gov/38795388/
2. Deng, Fengliu, Zhou, Rui, Lin, Chuang, Pan, Mingxin, Zhao, Liang. 2019. Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer. In Theranostics, 9, 1001-1014. doi:10.7150/thno.30056. https://pubmed.ncbi.nlm.nih.gov/30867812/
3. Iemura, Shunki, Kawao, Naoyuki, Akagi, Masao, Kaji, Hiroshi. 2020. Role of Dkk2 in the Muscle/bone Interaction of Androgen-Deficient Mice. In Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 129, 770-775. doi:10.1055/a-1331-7021. https://pubmed.ncbi.nlm.nih.gov/33352594/
4. Hu, Jiajia, Wang, Zhengting, Chen, Zhengxi, Wu, Dianqing, Xiao, Qian. 2020. DKK2 blockage-mediated immunotherapy enhances anti-angiogenic therapy of Kras mutated colorectal cancer. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 127, 110229. doi:10.1016/j.biopha.2020.110229. https://pubmed.ncbi.nlm.nih.gov/32559853/
5. Yang, Jianyu, Jiang, Yongsheng, He, Ruizhe, Zhang, Zhigang, Sun, Yongwei. 2019. DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. In Journal of immunology research, 2019, 8656282. doi:10.1155/2019/8656282. https://pubmed.ncbi.nlm.nih.gov/31583260/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
